The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Non-animal Capsule Market Research Report 2025
Synopsis
Non-animal Capsule is made by pullulan or hypromellose or starch.
The global Non-animal Capsule market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 178%.
This report aims to provide a comprehensive presentation of the global market for Non-animal Capsule, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-animal Capsule.
Report Scope
The Non-animal Capsule market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-animal Capsule market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-animal Capsule manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza (Capsugel)
ACG Associated Capsules
Qualicaps
Shanxi GS Capsule
CapsCanada
Suheung Capsule
Qingdao Capsule
Lefan Capsule
Sunil Healthcare
Catalent
Er-kang
Bahrain Pharma
Aenova
Procaps Laboratorios
SIRIO
Eurocaps
Best Formulations
Captek
Robinson Pharma
Segment by Type
Plant Polysaccharides
Starch
HPMC
Others
Segment by Application
Pharmaceutical
Health Supplements
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-animal Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-animal Capsule in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Non-animal Capsule is made by pullulan or hypromellose or starch.
The global Non-animal Capsule market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 178%.
This report aims to provide a comprehensive presentation of the global market for Non-animal Capsule, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-animal Capsule.
Report Scope
The Non-animal Capsule market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-animal Capsule market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-animal Capsule manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza (Capsugel)
ACG Associated Capsules
Qualicaps
Shanxi GS Capsule
CapsCanada
Suheung Capsule
Qingdao Capsule
Lefan Capsule
Sunil Healthcare
Catalent
Er-kang
Bahrain Pharma
Aenova
Procaps Laboratorios
SIRIO
Eurocaps
Best Formulations
Captek
Robinson Pharma
Segment by Type
Plant Polysaccharides
Starch
HPMC
Others
Segment by Application
Pharmaceutical
Health Supplements
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-animal Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-animal Capsule in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Non-animal Capsule Market Overview
1.1 Product Overview and Scope of Non-animal Capsule
1.2 Non-animal Capsule Segment by Type
1.2.1 Global Non-animal Capsule Market Value Comparison by Type (2024-2030)
1.2.2 Plant Polysaccharides
1.2.3 Starch
1.2.4 HPMC
1.2.5 Others
1.3 Non-animal Capsule Segment by Application
1.3.1 Global Non-animal Capsule Market Value by Application: (2024-2030)
1.3.2 Pharmaceutical
1.3.3 Health Supplements
1.3.4 Others
1.4 Global Non-animal Capsule Market Size Estimates and Forecasts
1.4.1 Global Non-animal Capsule Revenue 2019-2030
1.4.2 Global Non-animal Capsule Sales 2019-2030
1.4.3 Global Non-animal Capsule Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-animal Capsule Market Competition by Manufacturers
2.1 Global Non-animal Capsule Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-animal Capsule Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-animal Capsule Average Price by Manufacturers (2019-2024)
2.4 Global Non-animal Capsule Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-animal Capsule, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-animal Capsule, Product Type & Application
2.7 Non-animal Capsule Market Competitive Situation and Trends
2.7.1 Non-animal Capsule Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-animal Capsule Players Market Share by Revenue
2.7.3 Global Non-animal Capsule Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-animal Capsule Retrospective Market Scenario by Region
3.1 Global Non-animal Capsule Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-animal Capsule Global Non-animal Capsule Sales by Region: 2019-2030
3.2.1 Global Non-animal Capsule Sales by Region: 2019-2024
3.2.2 Global Non-animal Capsule Sales by Region: 2025-2030
3.3 Global Non-animal Capsule Global Non-animal Capsule Revenue by Region: 2019-2030
3.3.1 Global Non-animal Capsule Revenue by Region: 2019-2024
3.3.2 Global Non-animal Capsule Revenue by Region: 2025-2030
3.4 North America Non-animal Capsule Market Facts & Figures by Country
3.4.1 North America Non-animal Capsule Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-animal Capsule Sales by Country (2019-2030)
3.4.3 North America Non-animal Capsule Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-animal Capsule Market Facts & Figures by Country
3.5.1 Europe Non-animal Capsule Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-animal Capsule Sales by Country (2019-2030)
3.5.3 Europe Non-animal Capsule Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-animal Capsule Market Facts & Figures by Country
3.6.1 Asia Pacific Non-animal Capsule Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-animal Capsule Sales by Country (2019-2030)
3.6.3 Asia Pacific Non-animal Capsule Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-animal Capsule Market Facts & Figures by Country
3.7.1 Latin America Non-animal Capsule Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-animal Capsule Sales by Country (2019-2030)
3.7.3 Latin America Non-animal Capsule Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-animal Capsule Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-animal Capsule Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-animal Capsule Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-animal Capsule Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Non-animal Capsule Sales by Type (2019-2030)
4.1.1 Global Non-animal Capsule Sales by Type (2019-2024)
4.1.2 Global Non-animal Capsule Sales by Type (2025-2030)
4.1.3 Global Non-animal Capsule Sales Market Share by Type (2019-2030)
4.2 Global Non-animal Capsule Revenue by Type (2019-2030)
4.2.1 Global Non-animal Capsule Revenue by Type (2019-2024)
4.2.2 Global Non-animal Capsule Revenue by Type (2025-2030)
4.2.3 Global Non-animal Capsule Revenue Market Share by Type (2019-2030)
4.3 Global Non-animal Capsule Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-animal Capsule Sales by Application (2019-2030)
5.1.1 Global Non-animal Capsule Sales by Application (2019-2024)
5.1.2 Global Non-animal Capsule Sales by Application (2025-2030)
5.1.3 Global Non-animal Capsule Sales Market Share by Application (2019-2030)
5.2 Global Non-animal Capsule Revenue by Application (2019-2030)
5.2.1 Global Non-animal Capsule Revenue by Application (2019-2024)
5.2.2 Global Non-animal Capsule Revenue by Application (2025-2030)
5.2.3 Global Non-animal Capsule Revenue Market Share by Application (2019-2030)
5.3 Global Non-animal Capsule Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Lonza (Capsugel)
6.1.1 Lonza (Capsugel) Corporation Information
6.1.2 Lonza (Capsugel) Description and Business Overview
6.1.3 Lonza (Capsugel) Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Lonza (Capsugel) Non-animal Capsule Product Portfolio
6.1.5 Lonza (Capsugel) Recent Developments/Updates
6.2 ACG Associated Capsules
6.2.1 ACG Associated Capsules Corporation Information
6.2.2 ACG Associated Capsules Description and Business Overview
6.2.3 ACG Associated Capsules Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ACG Associated Capsules Non-animal Capsule Product Portfolio
6.2.5 ACG Associated Capsules Recent Developments/Updates
6.3 Qualicaps
6.3.1 Qualicaps Corporation Information
6.3.2 Qualicaps Description and Business Overview
6.3.3 Qualicaps Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Qualicaps Non-animal Capsule Product Portfolio
6.3.5 Qualicaps Recent Developments/Updates
6.4 Shanxi GS Capsule
6.4.1 Shanxi GS Capsule Corporation Information
6.4.2 Shanxi GS Capsule Description and Business Overview
6.4.3 Shanxi GS Capsule Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanxi GS Capsule Non-animal Capsule Product Portfolio
6.4.5 Shanxi GS Capsule Recent Developments/Updates
6.5 CapsCanada
6.5.1 CapsCanada Corporation Information
6.5.2 CapsCanada Description and Business Overview
6.5.3 CapsCanada Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CapsCanada Non-animal Capsule Product Portfolio
6.5.5 CapsCanada Recent Developments/Updates
6.6 Suheung Capsule
6.6.1 Suheung Capsule Corporation Information
6.6.2 Suheung Capsule Description and Business Overview
6.6.3 Suheung Capsule Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Suheung Capsule Non-animal Capsule Product Portfolio
6.6.5 Suheung Capsule Recent Developments/Updates
6.7 Qingdao Capsule
6.6.1 Qingdao Capsule Corporation Information
6.6.2 Qingdao Capsule Description and Business Overview
6.6.3 Qingdao Capsule Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qingdao Capsule Non-animal Capsule Product Portfolio
6.7.5 Qingdao Capsule Recent Developments/Updates
6.8 Lefan Capsule
6.8.1 Lefan Capsule Corporation Information
6.8.2 Lefan Capsule Description and Business Overview
6.8.3 Lefan Capsule Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lefan Capsule Non-animal Capsule Product Portfolio
6.8.5 Lefan Capsule Recent Developments/Updates
6.9 Sunil Healthcare
6.9.1 Sunil Healthcare Corporation Information
6.9.2 Sunil Healthcare Description and Business Overview
6.9.3 Sunil Healthcare Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sunil Healthcare Non-animal Capsule Product Portfolio
6.9.5 Sunil Healthcare Recent Developments/Updates
6.10 Catalent
6.10.1 Catalent Corporation Information
6.10.2 Catalent Description and Business Overview
6.10.3 Catalent Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Catalent Non-animal Capsule Product Portfolio
6.10.5 Catalent Recent Developments/Updates
6.11 Er-kang
6.11.1 Er-kang Corporation Information
6.11.2 Er-kang Non-animal Capsule Description and Business Overview
6.11.3 Er-kang Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Er-kang Non-animal Capsule Product Portfolio
6.11.5 Er-kang Recent Developments/Updates
6.12 Bahrain Pharma
6.12.1 Bahrain Pharma Corporation Information
6.12.2 Bahrain Pharma Non-animal Capsule Description and Business Overview
6.12.3 Bahrain Pharma Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Bahrain Pharma Non-animal Capsule Product Portfolio
6.12.5 Bahrain Pharma Recent Developments/Updates
6.13 Aenova
6.13.1 Aenova Corporation Information
6.13.2 Aenova Non-animal Capsule Description and Business Overview
6.13.3 Aenova Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Aenova Non-animal Capsule Product Portfolio
6.13.5 Aenova Recent Developments/Updates
6.14 Procaps Laboratorios
6.14.1 Procaps Laboratorios Corporation Information
6.14.2 Procaps Laboratorios Non-animal Capsule Description and Business Overview
6.14.3 Procaps Laboratorios Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Procaps Laboratorios Non-animal Capsule Product Portfolio
6.14.5 Procaps Laboratorios Recent Developments/Updates
6.15 SIRIO
6.15.1 SIRIO Corporation Information
6.15.2 SIRIO Non-animal Capsule Description and Business Overview
6.15.3 SIRIO Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.15.4 SIRIO Non-animal Capsule Product Portfolio
6.15.5 SIRIO Recent Developments/Updates
6.16 Eurocaps
6.16.1 Eurocaps Corporation Information
6.16.2 Eurocaps Non-animal Capsule Description and Business Overview
6.16.3 Eurocaps Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Eurocaps Non-animal Capsule Product Portfolio
6.16.5 Eurocaps Recent Developments/Updates
6.17 Best Formulations
6.17.1 Best Formulations Corporation Information
6.17.2 Best Formulations Non-animal Capsule Description and Business Overview
6.17.3 Best Formulations Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Best Formulations Non-animal Capsule Product Portfolio
6.17.5 Best Formulations Recent Developments/Updates
6.18 Captek
6.18.1 Captek Corporation Information
6.18.2 Captek Non-animal Capsule Description and Business Overview
6.18.3 Captek Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Captek Non-animal Capsule Product Portfolio
6.18.5 Captek Recent Developments/Updates
6.19 Robinson Pharma
6.19.1 Robinson Pharma Corporation Information
6.19.2 Robinson Pharma Non-animal Capsule Description and Business Overview
6.19.3 Robinson Pharma Non-animal Capsule Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Robinson Pharma Non-animal Capsule Product Portfolio
6.19.5 Robinson Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-animal Capsule Industry Chain Analysis
7.2 Non-animal Capsule Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-animal Capsule Production Mode & Process
7.4 Non-animal Capsule Sales and Marketing
7.4.1 Non-animal Capsule Sales Channels
7.4.2 Non-animal Capsule Distributors
7.5 Non-animal Capsule Customers
8 Non-animal Capsule Market Dynamics
8.1 Non-animal Capsule Industry Trends
8.2 Non-animal Capsule Market Drivers
8.3 Non-animal Capsule Market Challenges
8.4 Non-animal Capsule Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
